DEUTSCHE BANK AG\
BankPosition in ENTA — Enanta Pharmaceuticals Inc
CIK 948046
FRANKFURT AM MAIN, 2M
Position in ENTA
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$244,958
-$135,209 QoQ
Shares Held
19,395
-19.5% QoQ
Ownership
0.067%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ENTA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $2,973,536,998 across 248 Biotechnology names. ENTA ranks #196 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,537,736 | $686,660,626 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
625,388 | $483,199,777 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
761,464 | $251,945,590 | |
| 4 | INCY |
Incyte Corp
|
1,264,195 | $118,986,027 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,453,303 | $117,684,942 | |
| 6 | ARGX |
Argenx SE
|
139,381 | $101,782,972 | |
| 7 | INSM |
INSMED Inc
|
562,474 | $91,975,745 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
306,111 | $61,115,059 |
All Filings in ENTA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $244,958 | 19,395 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $380,167 | 24,107 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $275,932 | 23,052 | Shares | Defined | 2025-11-13 | |
| 2024-09-30 | $108,075 | 10,432 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $82,242 | 6,341 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $186,943 | 10,707 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $95,755 | 10,176 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $115,776 | 10,365 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $192,214 | 8,982 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $603,930 | 14,934 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $499,531 | 10,738 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $442,657 | 8,534 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $463,576 | 9,807 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $779,206 | 10,947 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $3,151,152 | 42,139 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $3,773,714 | 66,427 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $2,799,518 | 63,611 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $4,060,860 | 82,337 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $2,931,211 | 69,625 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $533,656 | 11,657 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $7,132,580 | 142,055 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $13,478,361 | 262,072 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||